PIH4 THE DIRECT AND INDIRECT COST BURDEN OF TREATED UTERINE FIBROIDS

Abstract

• But most assessments of the cost burden come from hospital-based studies, or studies that excluded information about productivity loss (Mauskopf, et al., 2005). • We used medical claims data from 92 self-insured employers to estimate the direct (medical) cost burden of leiomyoma. – We also used absenteeism and short-term disability records from a subset of women whose employers contributed those data to estimate the indirect cost burden of leiomyoma.